Cloning

Growth of the Ligation Devices Market to be Driven by High Demand from Elective and Minimally Invasive Surgeries: TMR

Retrieved on: 
Thursday, January 21, 2021
Cloning, Ligation, Market

As such, players in the global ligation devices market are tweaking their technical and engineering expertise to better medical outcomes.

Key Points: 
  • As such, players in the global ligation devices market are tweaking their technical and engineering expertise to better medical outcomes.
  • The global ligation devices market is estimated to be considerably influenced by its increasing use in endoscopic procedures.
  • All these factors are likely to play important role in fostering growth of the global ligation devices market in the forthcoming years.
  • This factor is estimated to restrain growth of the global ligation devices market in the near future.

A Data-Driven Workflow for Cell Line Development: How Productivity and Data Can Transform an Assurance-Based Workflow, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, January 21, 2021
Branches of biology, Biology, Stem cells, Cell culture, Business process, Groupware, Workflow, Cloning, Cell bank, Clone, Immortalised cell line

Cell line development workflows engage in isolation of single cells ('clonal derivation') followed by out-growth.

Key Points: 
  • Cell line development workflows engage in isolation of single cells ('clonal derivation') followed by out-growth.
  • Productivity measurements and critical quality attributes are employed in the characterization of leading clones for banking in Master Cell Banks.
  • This webinar explores ICON and STUDIUS from Solentim , two new products for cell line development.
  • For more information, or to register for this event, visit A Data-Driven Workflow for Cell Line Development: How Productivity and Data Can Transform an Assurance-Based Workflow.

Global Cord Blood Banking Industry Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 12, 2021
Biotechnology, General Health, Health, Branches of biology, Biology, Stem cells, Life sciences, Blood, Childbirth, Cloning, Cord blood bank, Sibling, Cord blood, Umbilical cord, Draft:Americord Registry

The "Global Cord Blood Banking Industry Report 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Cord Blood Banking Industry Report 2021" report has been added to ResearchAndMarkets.com's offering.
  • From the early 1900s through the mid-2000s, the global cord blood banking industry proliferated with cord blood banks emerging in all major healthcare markets worldwide.
  • Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular therapies, and an increasing trend toward industry consolidation.
  • Cord blood banks are diversifying into new types of stem cell storage, including umbilical cord tissue storage, placental blood and tissue, amniotic fluid and tissue, and dental pulp.

Global Bacterial and Plasmid Vectors Market Report 2020-2023 & 2030: COVID-19 Impacts, Growth and Change - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 12, 2021
Biotechnology, Science, Health, Research, Branches of biology, Molecular biology, Biology, Biochemistry, Gene delivery, Plasmid, Vector, Cloning, Biotechnology

The "Bacterial and Plasmid Vectors Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Bacterial and Plasmid Vectors Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
  • The bacterial and plasmid vectors market consists of sales of bacterial and plasmid vectors and related services by entities (organizations, sole traders and partnerships) that develop bacterial and plasmid vectors for biotechnological applications.
  • Global Bacterial and Plasmid Vectors Market, Segmentation by Host Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    4.2.
  • Global Bacterial and Plasmid Vectors Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Frequency Therapeutics to Present 2021 Business and Pipeline Overview at the 39th Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Tuesday, January 5, 2021
Health, Stem cells, Clinical trials, General Health, Pharmaceutical, Biotechnology, Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Cell biology, Cloning, Developmental biology, Progenitor cell

The presentation will be followed by a question and answer session to be held at 8:00 a.m.

Key Points: 
  • The presentation will be followed by a question and answer session to be held at 8:00 a.m.
  • A live webcast of both the presentation and the breakout session can be accessed on the investors section of Frequencys website, investors.frequencytx.com .
  • A replay of the presentation will be posted on the Frequency website following the event.
  • Frequency Therapeutics is a leader in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases.

Creative Medical Technology Holdings Announces Reversion of Liver Failure Using ImmCelz® Personalized Cellular Immunotherapy in Preclinical Model

Retrieved on: 
Tuesday, December 29, 2020
Branches of biology, Biology, Chemical compounds, Cell biology, Organ failure, Biotechnology, Cloning, Developmental biology, Stem cell, Liver, Carbon tetrachloride, Necrosis

PHOENIX, Dec. 29, 2020 /PRNewswire/ --(OTC-CELZ)Creative Medical Technology Holdings Inc. announced today novel data and patent filing No.

Key Points: 
  • PHOENIX, Dec. 29, 2020 /PRNewswire/ --(OTC-CELZ)Creative Medical Technology Holdings Inc. announced today novel data and patent filing No.
  • 63131261 describing the ability of ImmCelz to reverse liver failure in the carbon tetrachloride preclinical model of hepatocyte necrosis.
  • "ImmCelz is an advancement on our previous liver failure work due to the fact that we have shown transfer of regenerative activity from the stem cell to the immune cell.
  • See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov .

Global Cell Culture Market by Product, Application, End-user and Region - Forecast to 2025

Retrieved on: 
Friday, December 18, 2020
Life sciences, Biology, Branches of biology, Cell biology, Induced stem cells, Cloning, Developmental biology, Stem cell, Cell culture, Biotechnology, Biopharmaceutical, Cell

The global cell culture market is projected to reach USD 33.1 billion by 2025 from USD 19 billion in 2020, at a CAGR of 11.8% during the forecast period.

Key Points: 
  • The global cell culture market is projected to reach USD 33.1 billion by 2025 from USD 19 billion in 2020, at a CAGR of 11.8% during the forecast period.
  • Based on product, the cell culture market is segmented into equipment and consumables.
  • Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug screening & development, tissue engineering and regenerative medicine, and other applications.
  • Based on end-users, the cell culture market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals and diagnostic centers, and cell banks.

iQIYI Holds World's First Low-Resource Voice Cloning Challenge to Accelerate Development of AI Voice Technology

Retrieved on: 
Tuesday, December 15, 2020
Articles, Branches of biology, Asexual reproduction, Cloning, Cryobiology, Molecular biology, Biology, Educational technology, iQiyi, LIC

iQIYI released detailed guidelines for M2VoC, the first low-resource voice cloning challenge in the world, on 27 November.

Key Points: 
  • iQIYI released detailed guidelines for M2VoC, the first low-resource voice cloning challenge in the world, on 27 November.
  • iQIYI hopes that M2VoC will help to address these issues and accelerate the development of AI voice technology.
  • Through this challenge, iQIYI hopes to team up with talented researchers and build solutions for low-resource voice cloning with advanced deep-learning technology and multi-stylistic voice morphing technology.
  • The Company also anticipates that M2VoC will further elevate the interactive experience of video and drive the development and application of voice cloning technology.

Global Cell Culture Market (2020 to 2025) - Growing Demand for 3D Cell Culture Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, December 11, 2020
Health, Stem cells, Research, Pharmaceutical, Science, Biotechnology, Life sciences, Biology, Branches of biology, Cell biology, Induced stem cells, Cloning, Developmental biology, Stem cell, Cell culture, Biotechnology, Biopharmaceutical, Cell

The global cell culture market is projected to reach USD 33.1 billion by 2025 from USD 19 billion in 2020, at a CAGR of 11.8% during the forecast period.

Key Points: 
  • The global cell culture market is projected to reach USD 33.1 billion by 2025 from USD 19 billion in 2020, at a CAGR of 11.8% during the forecast period.
  • Based on product, the cell culture market is segmented into equipment and consumables.
  • Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug screening & development, tissue engineering and regenerative medicine, and other applications.
  • Based on end-users, the cell culture market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals and diagnostic centers, and cell banks.

Stem Holdings, Inc. Announces "On Your Mark" Quick Start to 2021 Expansion

Retrieved on: 
Tuesday, December 8, 2020
Articles, Cloning, Experiential learning, Mathematics education, Science education, Science, technology, engineering, and mathematics, Hash function, Cannabinoid, Queue, Terpene, Hash, Cutting

Stem has added a cutting-edge extraction laboratory to its commercial kitchen capabilities for full integration in production of these value-added, margin-accretive products.

Key Points: 
  • Stem has added a cutting-edge extraction laboratory to its commercial kitchen capabilities for full integration in production of these value-added, margin-accretive products.
  • Made with full spectrum solventless bubble hash, they are rich in cannabinoids and terpenes for consistent dosing and effectiveness.
  • This is just the beginning of a new queue of disruptive products unlike any other companys, stated Adam Berk, CEO of Stem.
  • Stem does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.